## **Core Concept**
The question targets the pharmacological management of motion sickness and vertigo, focusing on antiemetic drugs with less sedating properties. Motion sickness and vertigo are conditions that involve the vestibular system and are managed with drugs that either block histamine or muscarinic receptors.

## **Why the Correct Answer is Right**
The correct answer, **Scopolamine (D)**, is a muscarinic receptor antagonist that is well-known for its effectiveness in preventing motion sickness and managing vertigo. It works by blocking the action of acetylcholine at muscarinic receptors in the central nervous system and the vestibular system. Scopolamine is particularly noted for its efficacy in motion sickness and is often administered via a transdermal patch, which reduces systemic side effects and provides a steady dose over a prolonged period. Despite its anticholinergic effects, scopolamine is considered less sedating compared to antihistamines.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is blank and cannot be evaluated.
- **Option C:** This option is blank and cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **scopolamine** is often used in the form of a transdermal patch for motion sickness prophylaxis, especially for long-duration exposures like cruise ship voyages. It's less sedating compared to traditional antihistamines like dimenhydrinate, making it preferable for individuals who need to remain alert.

## **Correct Answer:** D. Scopolamine.